Centre Seeks NPPA Report on Hospital Consumable Markups Exceeding 2,800%

The Centre requested an NPPA report on significant price discrepancies in hospital consumables, with Maharashtra FDA flagging markups exceeding 2,800% between trade and maximum retail prices. HealthTech and medical devices platforms should audit supply-chain transparency immediately; regulators are now actively investigating margin stacking, and any B2B or B2C health-commerce player operating without documented cost-to-price alignment faces regulatory action.

Source: ET HealthWorld ↗